A. Temirbekov

A. Temirbekov

Auto-generated profile, based on publicly available information

A. Temirbekov

«Hospital of the Medical Center of the Office of the President of the Republic of Kazakhstan» RSE on REM

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
FBF. Bayembaev
F. Bayembaev
RRR. Rakhimzhanova
R. Rakhimzhanova
TDTairkhan Dautov
Tairkhan Dautov
ASA. Saduakasova
A. Saduakasova
ATA. Temirbekov
A. Temirbekov
Relevance: Positron emission tomography combined with computed tomography (PET/CT) is a young and promising technique for lymphoproliferative diseases’ primary detection, staging, and evaluation of the treatment results. However, at this stage of nuclear medicine development, some shortcomings in PET/CT diagnostics of lymphomas using 18Fluorodeoxyglucose (F18-FDG) affect its reliability to a certain extent. The study aimed to evaluate the physical and technical weaknesses of F18-FDG PET/CT in diagnosing lymphomas and review the analytical methods that affect opinion accuracy. Methods: The articles on the use of F18-FDG PET/CT in diagnosing lymphomas, its reliability, and methods for optimizing were searched in the PUBMED database for 2012-2022. Results: One of the main shortcomings of F18-FDG PET/CT in diagnosing lymphomas is the Deauville 5-point scale, which does not fully meet clinical requirements. This scale has some disadvantages, including low inter-reader agreement and an unreliable reference organ for F18-FDG accumulation. Mathematical algorithms for correction to the patient’s weight also require optimization. Conclusion: Some of the existing deficiencies can be improved at the software level and through educating staff about the importance of changing the SUV calculation method. However, other deficiencies, such as classifications that do not meet clinical requirements, require more efforts at the level of international experts and much more in-depth study of this issue to avoid such shortcomings of new staging methods. However, even considering all the shortcomings described, at the moment, PET/CT with F18-FDG is one of the most reliable modalities available, both for the initial detection and for evaluating the therapy effectiveness in patients with lymphomas.

31 March 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
FBF. Bayembaev
F. Bayembaev
RRR. Rakhimzhanova
R. Rakhimzhanova
TDTairkhan Dautov
Tairkhan Dautov
ASA. Saduakasova
A. Saduakasova
ATA. Temirbekov
A. Temirbekov
Relevance: Positron emission tomography combined with computed tomography (PET/CT) is a young and promising technique for lymphoproliferative diseases’ primary detection, staging, and evaluation of the treatment results. However, at this stage of nuclear medicine development, some shortcomings in PET/CT diagnostics of lymphomas using 18Fluorodeoxyglucose (F18-FDG) affect its reliability to a certain extent. The study aimed to evaluate the physical and technical weaknesses of F18-FDG PET/CT in diagnosing lymphomas and review the analytical methods that affect opinion accuracy. Methods: The articles on the use of F18-FDG PET/CT in diagnosing lymphomas, its reliability, and methods for optimizing were searched in the PUBMED database for 2012-2022. Results: One of the main shortcomings of F18-FDG PET/CT in diagnosing lymphomas is the Deauville 5-point scale, which does not fully meet clinical requirements. This scale has some disadvantages, including low inter-reader agreement and an unreliable reference organ for F18-FDG accumulation. Mathematical algorithms for correction to the patient’s weight also require optimization. Conclusion: Some of the existing deficiencies can be improved at the software level and through educating staff about the importance of changing the SUV calculation method. However, other deficiencies, such as classifications that do not meet clinical requirements, require more efforts at the level of international experts and much more in-depth study of this issue to avoid such shortcomings of new staging methods. However, even considering all the shortcomings described, at the moment, PET/CT with F18-FDG is one of the most reliable modalities available, both for the initial detection and for evaluating the therapy effectiveness in patients with lymphomas.

28 January 2026 in Наука и здравоохранение
Verified
Journal Article
Closed access
NAN.A. Axultanov
N.A. Axultanov
TDTairkhan Dautov
Tairkhan Dautov
VZViktor Zemlyanskiy
Viktor Zemlyanskiy
ITI.E. Ten
I.E. Ten
RRR.I. Rakhimzhanova
R.I. Rakhimzhanova
ATA.ZH. Temirbekov
A.ZH. Temirbekov
Introduction.Portal hypertension in cirrhosis remains a cause of complications (variceal bleeding, ascites, hypersplenism, hepatic encephalopathy); minimally invasive interventional tactics are indicated in a significant proportion of patients. Purpose of the study. To summarize data on the efficacy and safety of TIPS, BRTO/PARTO/CARTO, PTHVE and partial splenic artery embolization (PSE), as well as on portal pressure monitoring and postoperative management. Search strategy.Review (2005–2025) in PubMed/MEDLINE, Scopus, Web of Science, eLIBRARY; RCTs, cohort/retrospective studies, meta-analyses were included; observational studies, abstracts and outdated reviews were excluded. A total of 315 studies were identified, 58 of which were included in the analysis. Results. Endoscopic ligation provides primary hemostasis in 90–95% and, when combined with β-blockers, reduces recurrence by 40–50%; PTHVE – hemostasis 85–95%, 1-year recurrence ~15–20%, serious complications 3–5%; TIPS prevents recurrence in 80–90% of patients, PE 25–35%; the addition of embolization to TIPS reduces the risk of rebleeding (RR≈0.58), with post-TIPS PPG >12 mmHg – HR≈0.47; for gastric varices BRTO – success 90–95%, PE <5%, PARTO/CARTO are comparable; in refractory ascites TIPS reduces the recurrence rate by more than 70%; PSE increases platelet count by 40–60%: effect lasts ≥6–12 months. Optimization and monitoring: 8 mm stents reduce PE rate; success – HVPG reduction by ≥20–30% or <12 mmHg; Doppler signs of dysfunction – velocity 50% gradient; CT/MRI control at 4–6 weeks, ultrasound every 3 months. Conclusions. Interventional radiology is central; novelty – PPG-guided stratification (>12 mmHg), monitoring, solutions for PE reduction (8 mm stents); questions of transhepatic pressure measurement standardization and optimal intervention sequence remain, requiring prospective studies. Введение. Портальная гипертензия при циррозе остаётся причиной осложнений (варикозные кровотечения, асцит, гиперспленизм, печёночная энцефалопатия); у существенной доли пациентов показана минимально инвазивная интервенционная тактика. Цель исследования. Обобщить данные об эффективности и безопасности TIPS, BRTO/PARTO/CARTO, PTHVE и частичной эмболизации селезёночной артерии (PSE), а также о мониторинге портального давления и послеоперационном ведении. Стратегия поиска. Обзор (2005–2025) в PubMed/MEDLINE, Scopus, Web of Science, eLIBRARY; включались РКИ, когортные/ретроспективные исследования, мета-анализы; исключались наблюдения, тезисы и устаревшие обзоры. Идентифицировано 315 работ, в анализ вошли 58. Результаты. Эндоскопическое лигирование обеспечивает первичный гемостаз в 90–95% и при сочетании с β-блокаторами снижает рецидивы на 40–50%; PTHVE – гемостаз 85–95%, годичный рецидив ~15–20%, серьёзные осложнения 3–5%; TIPS предотвращает рецидив у 80–90% пациентов, ПЭ 25–35%; добавление эмболизации к TIPS уменьшает риск повторного кровотечения (RR≈0,58), при пост-TIPS PPG >12 мм рт. ст. – HR≈0,47; для желудочных вариксов BRTO – успех 90–95%, ПЭ <5%, PARTO/CARTO сопоставимы; при рефрактерном асците TIPS снижает частоту рецидивов более чем на 70%; PSE повышает уровень тромбоцитов на 40–60%: эффект ≥6–12 мес. Оптимизация и мониторинг: стенты 8 мм уменьшают частоту ПЭ; успех – снижение HVPG на ≥20–30% или <12 мм рт. ст.; допплер-признаки дисфункции – скорость 50% градиент; контроль КТ/МРТ на 4–6-й неделе, УЗИ каждые 3 месяца. Выводы. Интервенционная радиология занимает центральное место; новизна – PPG-ориентированная стратификация (>12 мм рт. ст.), мониторинг, решения для снижения ПЭ (8-мм стенты); остаются вопросы стандартизации чреспечёночного измерения давления и оптимальной последовательности вмешательств, требующие проспективных исследований. Кіріспе. Цирроз кезіндегі порталдық гипертензия асқынулардың себебі болып қалады (варикозды қан кету, асцит, гиперспленизм, бауыр энцефалопатиясы); аз инвазивті араласу тактикасы пациенттердің айтарлықтай бөлігінде көрсетілген. Мақсаты. TIPS, BRTO/PARTO/CARTO, PTHVE және ішінара көкбауыр артериясының эмболизациясының (PSE), сондай-ақ портал қысымын бақылау және операциядан кейінгі басқарудың тиімділігі мен қауіпсіздігі туралы деректерді...